Vigabatrin in the treatment of epilepsy: a long-term follow-up study.

Por Tartara, A, Manni, R, Galimberti, C A, Mumford, J P, Iudice, A, Perucca, E
Publicado em 1989

Effects of vigabatrin on evoked potentials in epileptic patients

Por Cosi, V., Callieco, R., Galimberti, C. A., Manni, R., Tartara, A., Mumford, J., Perucca, E.
Publicado em 1989

The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid.

Por Tartara, A, Galimberti, C A, Manni, R, Morini, R, Limido, G, Gatti, G, Bartoli, A, Strada, G, Perucca, E
Publicado em 1993

Differential effects of valproic acid and enzyme-inducing anticonvulsants on nimodipine pharmacokinetics in epileptic patients

Por Tartara, A., Galimberti, C.A., Manni, R., Parietti, L., Zucca, C., Baasch, H., Caresia, L., Mück, W., Barzaghi, N., Gatti, G., Perucca, E.
Publicado em 1991